Maple-Brown Abbott Imputation Fund


  • Asset Class
  • Australian Equities
  • Responsible Entity
  • Advance Asset Management Limited
  • APIR
  • ADV0013AU
  • ARSN
  • 087 294 504
  • Benchmark
  • S&P/ASX 200 Accumulation Index
  • Suggested Investment Period
  • 5+ Years
  • Fund Inception Date
  • 30 June 1986
  • Number of Stocks
  • 30-50
  • Income Distribution
  • Quarterly
  • Buy/Sell
  • Nil

Unit Price as at

17 May 2012

CURRENCY

AUD

REDEMPTION PRICE

0.9132

PURCHASE PRICE

0.9132

Overview

The Fund aims to provide a tax-effective income stream and long-term capital growth from a wide range of shares listed, or expected to be listed, on the Australian Securities Exchange.

The Fund aims to provide investors with a total investment return (before fees and taxes) that outperforms the S&P/ASX 200
Accumulation Index over periods of five years or longer.

Investment Strategy
The Fund aims to invest in a wide range of Australian shares, chosen for their perceived ‘fundamental value’. Cash plays an important part in managing the volatility of investment returns.

Maple-Brown Abbott seeks to buy investments that are priced at an attractive discount to their assessment of the investments’ underlying value. A key part of their investment process is a bottom up approach to stock selection and portfolio construction. Maple-Brown Abbott conducts their own proprietary research. Their investment philosophy and process has been consistently applied since 1984.

Important Information

Please see the Product Disclosure Statement (PDS) for further details. Although the above information is taken from sources believed to be accurate, no warranty is given as to its accuracy, completeness or availability. Neither Maple-Brown Abbott Limited, Advance Asset Management Limited, Ironbark Asset Management Limited nor any other person makes any representation nor gives any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any investment in the trusts shown on this website. This is general information only, and does not have regard to an investor's investment objectives, financial situation or needs.

Maple-Brown Abbott Imputation Fund Mar 2012 quarterly update


Overview


Dougal Maple-Brown, Head of Australian Equities (Maple-Brown Abbott), provides a quarterly update for the Maple-Brown Abbott Imputation Fund. Dougal discusses general equity market conditions, the contributors and detractors to the Fund’s quarterly performance and a brief outlook for the market.

Recorded: 23 Apr 2012 (2 mins 54 sec). Please refer to the support material for further information.

Important Information


Prepared by Ironbark Asset Management Pty Limited ABN 53 136 679 420 AFSL 341020 (‘Ironbark’).

Advance Asset Management Limited ABN 98 002 538 329 AFSL 240902 is the responsible entity of the Maple Brown-Abbott Imputation Fund and the Maple Brown-Abbott Australian Geared Equity Fund (Funds). Before deciding whether to acquire, or to continue to hold, an investment in a Fund, investors should obtain the Fund’s Product Disclosure Statement, available at ironbarkam.com or from your adviser and consider whether the product is appropriate for their circumstances.

This is general information only, and does not have regard to an investor’s investment objectives, financial situation or needs. Maple-Brown Abbott Limited ABN 73 001 208 564 AFSL 237296 and Ironbark do not make any representation or give any guarantee as to the future performance or success of, the rate of income or capital return from, the recovery of money invested in, or the income tax or other taxation consequences of, any investment.